Managing high-risk patients with acute coronary syndromes: The Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 4, Issue 4, 2004, Pages 369-375

  Collinson, J ^a,c   Perez De Arenaza, D ^c   Flather, Marcus D ^a,c,d,g   Bakhai, A ^c   Adgey, A A J ^b,e   Fox, K A A ^b,f  

^a Clinical Trials and Evaluation Unit   (United Kingdom)

^b Department of Cardiology ^*  (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute coronary syndromes; Clinical outcomes; Epidemiology; Prospective registry; Risk stratification; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STATINE DERIVATIVE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE COURSE; ELDERLY CARE; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; EXERCISE TEST; HEART BUNDLE BRANCH BLOCK; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; MORTALITY; RISK ASSESSMENT; ST SEGMENT DEPRESSION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED KINGDOM; UNSTABLE ANGINA PECTORIS;

EID: 4243075450     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-4-369     Document Type: Article

References (28)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy (Part 1 of 3): Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
2. Théroux P, Waters D, Shiqiang Q, McCans J et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993;88:2045-8.
3. Théroux P, Taeymans Y, Morissette D, Bosch X et al. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985;5:717-22.
4. Cohen M, Demers C, Gurfinkel EP, Turpie AGG et al. A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52.
5. Antman EM, Cohen M, Radley D, McCabe CH et al. Enoxaparin for unstable angina/non-Q wave myocardial infarction: meta-analysis of TIMI 11 B and ESSENCE (Abstract). J Am Coll Cardiol 1999;33:351A.
6. Antman EM, McCabe CH, Gurfinkel EP, Turpie AGG et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation 1999;100:1593-601.
7. Fragmin and Fast Revascularisation during Instability in Coronary Artery Disease (FRISC II) Investigators. Long-term low molecular mass heparin in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:701-7.
8. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptìfibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
9. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-505.
10. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
11. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
12. Fragmin and Fast Revascularisation during Instability in Coronary Artery Disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
13. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N EngI J Med 2001;344:1879-87.
14. Wallentin L, Lagerqvist B, Husted S, Kontny F et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease. Lancet 2000;356:9-16.
15. Braunwald E, Antman EM, Beasley JW, Califf RM et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST elevation myocardial infarction: Executive summary and Recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with unstable angina). Circulation 2000;102:1193-209.
16. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST elevation: Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000;21:1406-32.
17. Collinson J, Flather MD, Fox KAA, Findlay I et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21:1450-7.
18. Fox KAA, Goodman SG, Klein W, Brieger D et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
19. Hasdai D, Behar S, Wallentin L, Danchin N et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23:1190-201.
20. Brady AJB, Oliver MA, Pittard B. Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care. BMJ 2001;322:1463.
21. Braunwald E, Antman EM, Beasley JW, Califf RM et al. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. 2002: summary article. Circulation 2002;106:1893-1900.
22. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-40.
23. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P et al. The prognostic value of serum troponin T in unstable angina [see Comments]. NEngl J Med 1992;327:146-50.
24. Ohman EM, Armstrong PW, Christenson RH, Granger CB et al. Cardiac troponin T levels for risk stratification in acute myocardial ischaemia. GUSTO IIA Investigators. N Engl J Med 1996;335:1333-41.
25. Antman EM, Tanasijevic MJ, Thompson B, Schactman M et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335: 1342-9.
26. Wilcox I, Freedman SB, Allman KC, Collins FL et al. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina. J Am Coll Cardiol 1991;18:677-83.
27. Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. N Engl J Med 1998;339:1882-8.
28. Antman EM, Cohen M, Bernink PJL, McCabe CH et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.